RxDoctor Payments Data

David Rabinovici

Neurology · Flushing, NYNPI 1609890599

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 220 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 53.6% of the total. Reporting peaked in 2021 at $1,324 and has fallen 98.7% since, to $17 in 2024.

$3,637in general payments, 2019–2025

Across 220 payments — averaging $16.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Biohaven Pharmaceutical Holding Company Ltd.$388
  • Biohaven Pharmaceuticals, Inc.$350
  • UCB, Inc.$189
  • Sanofi$159
  • Teva Pharmaceuticals USA, Inc.$85
  • plus $517 from 17 others

What the payments were for

  • Food & beverage$3,61899%
  • Education$191%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,637 in reported general payments places this provider in the 65th percentile of 1,623 neurology providers in New York.

See all neurology providers in New York →

Other neurology in Flushing

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →